U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H26O3
Molecular Weight 302.4079
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 19-HYDROXYANDROSTENEDIONE

SMILES

C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34CO)[C@@H]1CCC2=O

InChI

InChIKey=XGUHPTGEXRHMQQ-BGJMDTOESA-N
InChI=1S/C19H26O3/c1-18-8-7-16-14(15(18)4-5-17(18)22)3-2-12-10-13(21)6-9-19(12,16)11-20/h10,14-16,20H,2-9,11H2,1H3/t14-,15-,16-,18-,19+/m0/s1

HIDE SMILES / InChI

Molecular Formula C19H26O3
Molecular Weight 302.4079
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
[The newly developed method of 19-OH-A as intermediate of estrone biosynthesis by GC-MS].
1989-08-20
Endocrine regulation of cytochrome P-450 in the rat brain and pituitary gland.
1989-07
Formation of 4-oestrene-3,17-dione (19-norandrostenedione) by porcine granulosa cells in vitro is inhibited by the aromatase inhibitor 4-hydroxyandrostenedione and the cytochrome P-450 inhibitors aminoglutethimide phosphate and ketoconazole.
1989-02
Dissociation of 19-hydroxy- 19-oxo-, and aromatizing-activities in human placental microsomes through the use of suicide substrates to aromatase.
1989-02
Aromatase and nonaromatizing 10-demethylase activity of adrenal cortex mitochondrial P-450(11)beta.
1988-11-15
Formation and metabolism of 5(10)-estrene-3 beta,17 beta-diol, a novel 19-norandrogen produced by porcine granulosa cells from C19 aromatizable androgens.
1988-08-30
[A study of non-aromatizing androgen 19-hydroxylase in sheep adrenal].
1988-07-20
Synthesis of c-2, 3, 17 and 19-oxygenated androgens.
1988-03
Metabolism of 19-methyl-substituted steroids by human placental aromatase.
1987-12-01
Enhancement of the hypertensinogenic action of 19-hydroxyandrostenedione by aromatase inhibitor, delta 1-testololactone.
1987-12
An improved in vitro bioassay for follicle-stimulating hormone (FSH): suitable for measurement of FSH in unextracted human serum.
1987-09
Imidazole antimycotics: selective inhibitors of steroid aromatization and progesterone hydroxylation.
1987-07-01
Plasma androstenedione in normotensive and hypertensive pregnancy.
1986-11-01
A reevaluation of the mineralocorticoid and hypertensinogenic potential of 19-hydroxyandrostenedione.
1986-06
3-Methylene-substituted androgens as novel aromatization inhibitors. Evidence of a requirement for C-3 oxygen in C-19 hydroxylations.
1986-05-25
P-45011 beta-dependent conversion of cortisol to cortisone, and 19-hydroxyandrostenedione to 19-oxoandrostenedione.
1986-04-14
Role of substrate conformational features in the stereospecificity of aromatase.
1986-02-11
Digoxin-like immunoreactivity of 19-NOR and 19-OH-androst-4-ene-3,17-dione.
1986
Aromatase activity in the perinatal rat forebrain: effects of age, sex and intrauterine position.
1985-12
Angiotensin II induces the release of 19-hydroxyandrostenedione in man.
1985-08
Androgen aromatization and 5 alpha-reduction in ferret brain during perinatal development: effects of sex and testosterone manipulation.
1985-05
Radiometric analysis of oxidative reactions in aromatization by placental microsomes. Presence of differential isotope effects.
1985-01-10
[A comparative study of C19 steroid-induced hypertension and deoxycorticosterone acetate (DOCA)-salt hypertension].
1984-11-20
Changes in oestrogen-synthesizing ability of preovulatory bovine follicles relative to the peak of LH.
1984-11
[New mineralocorticoids and mineralocorticoid-like steroids].
1984-11
In vitro conversion of androgen to estrogen in amphioxus gonadal tissues.
1984-10
Studies on cytochrome P-450-dependent microsomal enzymes of testicular androgen and estrogen biosynthesis in a urodele amphibian, Necturus.
1984-07
Methyltrienolone (R1881) is not aromatized by placental microsomes or rat hypothalamic homogenates.
1984-05
19-hydroxyandrostenedione and 6 beta-hydroxyandrostenedione: new steroids regulated by the renin-angiotensin system in man.
1984-01
19-Hydroxyandrostenedione: evidence for a new class of sodium-retaining and hypertensinogenic steroids.
1983-09
19-Hydroxyandrostenedione: a potent hypertensinogenic steroid in man.
1983-07
6 beta-Hydroxyandrostenedione: evidence for a new hypertensinogenic agent.
1983
Effects of age and 1,4,6-androstatriene-3,17-dione on activities of hCG-induced 19-hydroxylase and aromatase of rat testes.
1982-08
19-hydroxyandrostenedione, a new amplifier of the action of aldosterone, in low renin essential hypertension.
1982-04
Evidence that 19-hydroxyandrostenedione is secreted by the adrenal cortex and is under the control of ACTH and the renin-angiotensin system in man.
1982-03-30
Mechanistic studies on C-19 demethylation in oestrogen biosynthesis.
1982-03-01
19-hydroxyandrostenedione as a new hypertensinogenic agent.
1982-02
Improved in vitro bioassay of follitropin.
1982
Evidence that granulosa cell aromatase induction/activation by follicle-stimulating hormone is an androgen receptor-regulated process in-vitro.
1981-10
Identification of estradiol produced by Sertoli cell enriched cultures during incubation with testosterone.
1981-06
FSH induction of aromatase in cultured rat granulosa cells measured by a radiometric assay.
1981-05
10 beta-propynyl-substituted steroids. Mechanism-based enzyme-activated irreversible inhibitors of estrogen biosynthesis.
1981-02-10
Human fatty marrow aromatizes androgen to estrogen.
1980-08
Steroid structure and function--VI. The molecular conformation of 19-hydroxy-4-androstene-3,17-dione, as an intermediate for estrogen synthetase.
1980-04
A sensitive and specific in vitro bioassay method for the measurement of follicle-stimulating hormone activity.
1979-06
Amplification of the action of subthreshold doses of aldosterone by 19-hydroxyandrost-4-ene-3, 17-dione.
1979-04-13
Metabolism of 19-hydroxyandrostenedione in human subjects. Urinary excretion of conjugates.
1978-03
Aromatization of delta4-androstene-3,17-dione, 19-hydroxy-delta4-androstene-3,17-dione, and 19-oxo-delta4-androstene-3,17-dione at a common catalytic site in human placental microsomes.
1977-01-11
The aromatization of androgens by primary monolayer cultures of fetal rat hypothalamus.
1977-01
The role of 19-hydroxy-delta4-androstene-3,17-dione in the conversion of circulating delta4-androstene-3, 17-dione to estrone.
1976-07
Patents
Substance Class Chemical
Created
by admin
on Tue Apr 01 16:23:53 GMT 2025
Edited
by admin
on Tue Apr 01 16:23:53 GMT 2025
Record UNII
A546CQ0584
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
19-HYDROXYANDROSTENEDIONE
Systematic Name English
C05290
Preferred Name English
(8R,9S,10S,13S,14S)-10-(HYDROXYMETHYL)-13-METHYL-2,6,7,8,9,11,12,14,15,16-DECAHYDRO-1H-CYCLOPENTA(A)PHENANTHRENE-3,17-DIONE
Systematic Name English
J117.011B
Code English
4-ANDROSTENE-3,17-DIONE-19-OL
Common Name English
19-HYDROXYANDROST-4-ENE-3,17-DIONE
Systematic Name English
ANDROST-4-EN-19-OL-3,17-DIONE
Common Name English
4-ANDROSTEN-19-OL-3,17-DIONE
Common Name English
ANDROST-4-ENE-3,17-DIONE-19-OL
Common Name English
NSC-74233
Code English
19-HYDROXY-4-ANDROSTENE-3,17-DIONE
Systematic Name English
19-HAED
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID80199007
Created by admin on Tue Apr 01 16:23:53 GMT 2025 , Edited by admin on Tue Apr 01 16:23:53 GMT 2025
PRIMARY
CAS
510-64-5
Created by admin on Tue Apr 01 16:23:53 GMT 2025 , Edited by admin on Tue Apr 01 16:23:53 GMT 2025
PRIMARY
PUBCHEM
252379
Created by admin on Tue Apr 01 16:23:53 GMT 2025 , Edited by admin on Tue Apr 01 16:23:53 GMT 2025
PRIMARY
ECHA (EC/EINECS)
208-116-5
Created by admin on Tue Apr 01 16:23:53 GMT 2025 , Edited by admin on Tue Apr 01 16:23:53 GMT 2025
PRIMARY
NSC
74233
Created by admin on Tue Apr 01 16:23:53 GMT 2025 , Edited by admin on Tue Apr 01 16:23:53 GMT 2025
PRIMARY
SMS_ID
300000052979
Created by admin on Tue Apr 01 16:23:53 GMT 2025 , Edited by admin on Tue Apr 01 16:23:53 GMT 2025
PRIMARY
FDA UNII
A546CQ0584
Created by admin on Tue Apr 01 16:23:53 GMT 2025 , Edited by admin on Tue Apr 01 16:23:53 GMT 2025
PRIMARY
CHEBI
27576
Created by admin on Tue Apr 01 16:23:53 GMT 2025 , Edited by admin on Tue Apr 01 16:23:53 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> METABOLITE